Synektik SA GPW:SNT:
POLAND'S KNF APPROVES SYN2BIO PROSPECTUS FOR SPIN-OFF FROM COMPANY
SAYS SYN2BIO DEBUT ON WARSAW STOCK EXCHANGED PLANNED FOR AROUND APRIL 16
Synektik Says KNF Approves Syn2bio Prospectus For Spin-Off
Story so far
Earlier from Synektik
- Synektik Signs Deal With Hospital In Grudziadz For Da Vinci System
- SNT: Double-digit revenue and profit growth, robust recurring income, and strategic expansion initiatives
- Synektik To Transfer Organized Part Of Enterprise Related To Cardiomarker And CBNC To Syn2bio
- Synektik Expands And Extends Distribution Agreement With Intuitive Surgical
- Synektik Signs 18.3 Mln Zloty Deal For Delivery For Da Vinci System
Later from Synektik
- Synektik Signs 21.2 Mln Zloty Deals With University Clinical Center In Gdansk For Da Vinci 5 System
- Synektik Signs 30.0 Mln Zloty Deals For Delivery Of Da Vinci System
- Synektik Secures Orders Worth About 163 Million Zlotys In Q2
- Syn2bio shares halted at Warsaw Stock Exchange debut
- Synektik Estimates H1 Consolidated Revenue At About 441 Million Zlotys
Follow Synektik into a list and get an email when it puts out news.
Follow Synektik